CF CAN TRANSCATHETER HEART VALVE REPAIR, REPLACEMENT AND ASSOCIATED DEVICES

Award

Buyers

Supply Chain Coordination Limited

Value

£800,000,000

Suppliers

Classifications

Medical equipments

Tags

award

Submission Deadline

2 years ago

Published

1 day ago

Description

NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply of percutaneous valve repair and replacement devices to NHS Supply Chain customers via the non-direct route of supply.
Certain products within this framework agreement are classified as high cost tariff excluded devices under the NHS England Specialised Services Devices Programme (SSDP) (formerly known as the High-Cost Tariff-Excluded Devices programme) . Trusts who are commissioned to provide specialised services in England are directed to purchase all their SSDP requirements through a national supply route via NHS Supply Chain.
It is anticipated that initial expenditure will be in the region of £130,000,000 to £160,000,000  in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £880,000,000

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download

Similar Contracts

Open

Supply and Support of Complete Antibody Quantification Testing Systems

The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.

Published 2 days ago

Open

Supply and Maintenance of a Cord Blood Cell Separation System and associated consumables

NHS Blood and Transplant is leading a procurement for the provision and maintenance of a Cord Blood Cell Separation System and associated consumables. We are looking to appoint one (1) Supplier for the provision of this requirement. The Cord Blood Bank (CBB) forms part of the Clinical Services Directorate of NHSBT. The CBB laboratory provides services to support haematopoietic stem cell transplantation including collection, processing and cryopreservation of cord blood derived stem cells. Cord blood is rich in blood stem cells, similar to those found in bone marrow, and these can be used to treat many different cancers, immune deficiencies and genetic disorders. For the transplant to be a success, stem cells taken from the cord blood must match the patient's tissue type as closely as possible.

Published 2 days ago

Open

Southend Day Surgery Unit Managed Services Operator

Mid and South Essex Foundation Trust (“the Authority”) hereby invites suitably experienced managed services operators to submit Tenders for the provision of managing and operating the Southend 23 hour Day Surgery Unit. The Authority is carrying out this tender process under the competitive flexible procedure, and anticipates incorporation of limited negotiation with bidders on areas such as the contract terms, the commercial offer template and KPIs. The Authority is developing a dedicated Day Surgery Unit and 23 hour Ward to re-provide and replace elective surgical capacity and address growing demand and waiting list pressures. The facility will be a ring-fenced, standalone elective care centre connected to the main hospital to ensure access to inpatient services and diagnostics when required. This model will ensure the delivery of a high-quality, sustainable, and efficient elective surgical service for Mid and South Essex, aligning with national elective recovery priorities. The Authority is seeking to commission a fully managed service offer, providing the operational management and everything from the equipment to the required minimum specification, equipment installation, maintenance and consumables for NHS clinical teams and potential to contract with the independent and private sector organisations to use. The primary objectives of the unit is to: • Provide a modern fit for purpose environment for day surgery theatres which supports the Authority’s strategy for being at the leading edge of surgery (through cutting edge equipment and responsiveness) that allows the maximum benefit for the Mid and South Essex population. • Implement high-volume, low-complexity surgical pathways in line with Getting It Right First Time (GIRFT) principles. • Support recruitment and retention by providing a dedicated and purpose-built environment. The new 1900m² facility will form a fully functional, well maintained and operational suite and will comprise: • 2 Theatres (laminar flow enabled) for a range of elective procedures. • 1 Enhanced Treatment/Procedure Room for outpatient-based interventions. • Pre- and post-operative recovery areas, including 8 patient pods and 2 ensuite side rooms. • General spaces: Waiting, administration, admission and discharge areas, and staff welfare facilities. The expectation is that the below specialities (in the form of elective day-case and 23-hour stay surgeries) will use the facilities, but this is expected to evolve over the life of the contract: • ENT • General Surgery • Pain Management • Oral Surgery • Gynaecology • Burns and Plastics • Orthopaedics (excluding complex procedures requiring a clean facility) • Urology. This equates to circa 4,500 procedures per annum. In addition to providing the aforementioned services, the managed services operator will be required to enter into a separate lease arrangement for the building with a specialist developer. To enable the funding and delivery of the building, the Authority has appointed a specialist developer to deliver the whole building and the fitout of the ground floor Day Surgery Unit. The funding of the project will require an established leasing structure to be implemented. This will therefore require the managed services operator to enter into lease agreements with the developer. Lot Information: The Authority has determined that splitting the contract into lots is not appropriate for this procurement. This decision is based on the following considerations: • Operational Integration: The services required for the bidder encompass a comprehensive and integrated approach to managing and operating the facility. Splitting the contract into lots would disrupt the seamless delivery of services, including clinical governance, equipment management, staffing, and patient safety protocols. • Efficiency and Coordination: The nature of the services demands high levels of coordination and efficiency across various operational areas. Dividing the contract into separate lots would lead to fragmented management, potentially compromising the quality and responsiveness of service delivery. • Specialised Expertise: The bidder is expected to provide specialised expertise in managing a high-quality surgical facility. This includes adherence to NHS standards, regulatory compliance, and continuous improvement initiatives. A single contract ensures that the bidder can leverage its full range of skills and resources without the complications of managing multiple contractors. • Financial and Contractual Obligations: The financial structure of the contract, including lease payments and revenue generation, requires a unified approach to ensure transparency and compliance with NHS financial governance standards. Splitting the contract could lead to inconsistencies and challenges in financial management. • Innovation and Service Development: The bidder is tasked with implementing continuous innovation and service development, including digital health technologies, personalised patient care, and sustainability initiatives. A single contract allows for a cohesive strategy and streamlined implementation of these advancements. • Governance and Performance Monitoring: Effective governance and performance monitoring are critical to the success of the bidder. A single contract facilitates clear accountability and consistent reporting, ensuring that all aspects of service delivery are aligned with the Authority's strategic objectives.

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

Supply Chain Coordination Limited

Ministry or any other national or federal authority, including their regional or local subdivisions

NHS Supply Chain Operated by Health Solutions Team Limited acting as agent of Supply Chain Coordination Ltd (SCCL)

[email protected]

Timeline complete

Publish

Bid

Evaluate

Award

Complete